The Claim
In primary microvascular endothelial cells isolated from rat hindlimb muscle, a 24-hour incubation with glucose-dependent insulinotropic polypeptide (GIP) increases endothelin-1 (ET-1) production in a dose-dependent manner and inhibits glucagon-like peptide-1 (GLP-1)–stimulated nitric oxide (NO) production, indicating that GIP may regulate vascular tone through dual opposing effects on vasoconstrictive and vasodilatory pathways.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In rat blood vessel cells, a hormone called GIP makes the vessels tighter by boosting a constricting chemical and blocking a relaxing one — suggesting it can push blood flow in two opposite directions at once.
See the scientific wording
In primary microvascular endothelial cells isolated from rat hindlimb muscle, 24-hour incubation with GIP increases endothelin-1 (ET-1) production in a dose-dependent manner and inhibits GLP-1–stimulated nitric oxide (NO) production, suggesting GIP may regulate vascular tone through opposing effects on vasoconstrictive and vasodilatory pathways.
What the research says
1 studyStudy: 109-OR: GIP Acutely Blunts Insulin- and GLP-1–Induced Muscle Microvascular Perfusion
The study tested exactly what the claim says: treating rat muscle blood vessel cells with GIP for 24 hours increased a substance that tightens blood vessels and blocked a substance that loosens them, which matches the claim perfectly.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.